S&P Picks and Pans: Activision, Amgen, Lennar, Tribune (BusinessWeek)
Analysts' opinions of stocks in the news

Anika Therapeutics and Galderma Complete Termination of License, Development and Supply Agreements (Finanzen.net)
Anika Therapeutics, Inc. (Nasdaq: ANIK) today announced that Anika and Galderma Pharma S.A. and Galderma S.A. (together, "Galderma ) have closed on their agreement to terminate all license, development and supply arrangements among ...

Progress Is Being Made Toward Approval Of Generic Biotechnology Drugs (Medical News Today)
The U.S. slowly is making progress toward developing a regulatory pathway that would allow FDA to approve generic versions of biotechnology drugs, experts from the generic drug industry told attendees of the 10th annual International Generic Pharmaceutical Alliance conference in Miami Beach on Thursday, the Miami Herald reports. [click link for full article]